Last edition
News about "RNAi Therapeutics "
Eli Lilly and SanegeneBio Partner to Develop RNAi Therapies for Metabolic Diseases
SanegeneBio, a clinical-stage biotechnology company developing RNAi therapeutics, has entered into a global research and licensing collaboration with Eli Lilly and Company to advance RNAi candidates for metabolic diseases.
RNAi Therapeutics | 10/11/2025 | By Dineshwori | 193
Scenic Biotech Partners with Alnylam to Advance RNAi Therapeutics Using Cell-Seq Platform
This collaboration represents Scenic Biotech’s third Cell-Seq collaboration with major US biotech and pharmaceutical companies, following ongoing multi-year agreements with Genentech and Bristol Myers Squibb. <br />
RNAi Therapeutics | 26/08/2025 | By Dineshwori | 229
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy